Taipei, Taiwan

Yun Yu


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Yun Yu from Taipei, TW

Introduction

Yun Yu is a notable inventor based in Taipei, Taiwan. With a remarkable ability to create impactful solutions, he holds a patent that showcases his commitment to innovation in the pharmaceutical field.

Latest Patents

Yun Yu has been granted one patent for his invention titled "Ammonium salts of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-one and uses thereof." This patent is significant as it introduces a compound that acts as an ammonium salt of GW5074. The compound can help in treating cancers by involving a complex method of detecting specific cellular markers and administering a tailored treatment plan. The patent includes a pharmaceutical kit that combines c-Raf inhibitors with the compound, aiming to enhance efficacy in cancer treatment.

Career Highlights

Yun Yu is currently associated with Metagone Biotech Inc., where he continues to push the boundaries of medical science through his research and innovative spirit. His contributions are vital in developing treatments that have the potential to combat various forms of cancer.

Collaborations

Throughout his career, Yun has collaborated with notable colleagues, including Tai-Lung Cha and Tai-Wei Ly. Their joint efforts underscore the importance of teamwork in advancing research and the development of groundbreaking pharmaceutical applications.

Conclusion

Inventor Yun Yu exemplifies the spirit of innovation in the field of pharmaceuticals. With his patent, he not only showcases his ingenuity but also contributes to the ongoing fight against cancer, reflecting a dedication to improving healthcare outcomes. His work continues to inspire future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…